hotspot -WSS

hotspot

author：leisure time 2025-08-12 09:08:32 - browse：875

Susan Galbraith of AstraZeneca gestures while speaking – pharma coverage from STAT — Susan Galbraith, AstraZeneca’s head of cancer research and development, speaks at a STAT event in 2023. Marie Miller for STAT

CHICAGO — AstraZeneca’s head of cancer research and development, Susan Galbraith, is British, and prone to a particularly British style of understatement. She doesn’t boast loudly. But she did come to this year’s annual meeting of the American Society of Clinical Oncology wearing a small lapel pin with the numeral 6 and the “AZ” corporate logo.

That pin represents the number of years in a row that the London-based drug giant has had a presentation in the ASCO plenary, the conference’s biggest showcase for new data. This year, the company has two.

Scientific credibility is great, of course. But AstraZeneca’s shareholders want something else: return on investment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Virtual Event: March of the Biosimilars

WSS

Methadone treatment changes are coming. Do they go far enough?

The kidney, in all its complexity, is captured in a new atlas

Neuroscience’s long legacy of racism

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Positive childhood experiences can help future health

Plane’s emergency slide plummets from sky, hits Chicago home

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Bright Health sells Medicare Advantage business to Molina

Argenx readies a blockbuster opportunity with drug for autoimmune disease

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Seattle police shoot person suspected in downtown stabbing

Virginia high school admissions case could be legal follow

CVS Caremark has created a new ploy: the drug ‘rebate credit’

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

BioMarin wins approval for gene therapy to treat hemophilia A

Resistance to cancer drugs: A new genetic explanation

knowledge

Medical experts are missing from AI regulatory conversations

Seattle police shoot person suspected in downtown stabbing

Researchers separate signal from noise in heart wearable data

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

The kidney, in all its complexity, is captured in a new atlas

'Reaching a detente': STAT's Helen Branswell on covering Covid

Wikipedia

hotspot

Wikipedia

focus